Random-effects meta-analysis of phase I dose-finding studies using stochastic process priors
From MaRDI portal
Publication:2233150
DOI10.1214/20-AOAS1390zbMath1475.62269arXiv1908.06733OpenAlexW2967965553MaRDI QIDQ2233150
Sarah Zohar, Moreno Ursino, Tim Friede, Christian Roever
Publication date: 14 October 2021
Published in: The Annals of Applied Statistics (Search for Journal in Brave)
Full work available at URL: https://arxiv.org/abs/1908.06733
Estimation in multivariate analysis (62H12) Gaussian processes (60G15) Applications of statistics to biology and medical sciences; meta analysis (62P10)
Related Items (2)
Uses Software
Cites Work
- Unnamed Item
- Unnamed Item
- Unnamed Item
- Unnamed Item
- Unnamed Item
- Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer
- Covariates and random effects in a Gamma process model with application to degradation and failure
- A weakly informative default prior distribution for logistic and other regression models
- Optimal Bayesian-feasible dose escalation for cancer phase I trials
- The Brownian movement and stochastic equations
- Statistical Methods for Dose‐Finding Experiments
- Determining the Effective Sample Size of a Parametric Prior
- Meta‐analysis of two studies in the presence of heterogeneity with applications in rare diseases
- Combining Multiple Comparisons and Modeling Techniques in Dose‐Response Studies
This page was built for publication: Random-effects meta-analysis of phase I dose-finding studies using stochastic process priors